source
- Philips earmarks $322 million for pending DOJ settlement on sleep-apnea device recallPhilips' Respironics division announced it has reached an agreement in principle with the U.S. Department of Justice to settle the investigation into its sleep‑apnea device recall. The recall, ini…
- UniQure slated for FDA decision by May 1 as analysts see potential for first Huntington’s disease therapyUniQure said the Food and Drug Administration has set a decision date for its Huntington's disease gene therapy and is likely to hold an advisory committee meeting. The agency indicated a faster‑th…